{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:34:32Z","timestamp":1791488072821,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.11.011","type":"journal-article","created":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T12:16:37Z","timestamp":1132229797000},"page":"2169-2175","source":"Crossref","is-referenced-by-count":83,"title":["Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis"],"prefix":"10.1016","volume":"24","author":[{"given":"Sima","family":"Rafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Zahedifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Nazgouee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.011_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-2776(08)60912-8","article-title":"The host response to Leishmania infection","volume":"74","author":"Solbach","year":"2000","journal-title":"Adv Immun"},{"key":"10.1016\/j.vaccine.2005.11.011_bib2","first-page":"162","article-title":"Immunology of leishmaniasis","volume":"32","author":"Liew","year":"1993","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmania: current status of vaccine development","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2005.11.011_bib4","doi-asserted-by":"crossref","unstructured":"Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in Western Upper Nile, Southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25:862.","DOI":"10.1093\/ije\/25.4.862"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2005.11.011_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","article-title":"The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms","author":"Olivier","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2005.11.011_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1179\/000349803225002570","article-title":"Nigro L. visceral leishmaniasis with those infected with HIV: clinical aspects and other opportunistic infections","volume":"97","author":"Russo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib7","doi-asserted-by":"crossref","unstructured":"Khalil EAG, Hassan MEI, Zylstra EE, Mukhtar MM, Ghalib HW, Breyma M, et al. Autoclaved Leishmania major vacine for prevention of visceral leishmaniasis: a randomised, double blinde-bind, BCG-controled trial in Sudan. Lancet 2000;356.","DOI":"10.1016\/S0140-6736(00)03128-7"},{"key":"10.1016\/j.vaccine.2005.11.011_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"19","author":"DE Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib9","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-Quil A saponine vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib10","unstructured":"http:\/\/www.micro.unsw.edu.au\/Micro305\/2001\/sasson gately Karikios."},{"key":"10.1016\/j.vaccine.2005.11.011_bib11","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.011_bib12","first-page":"1","article-title":"Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani","volume":"3347","author":"Sukumaran","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib13","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0264-410X(00)00398-4","article-title":"Immunization with DNA encoding Leishmania infantum protein Paple22 decreases the frequency of parasitemic episodes in infected hamsters","volume":"19","author":"Fragaki","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib14","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against cutaneous leishmaniasis with DNA encoding cystein proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0264-410X(02)00189-5","article-title":"Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB\/c mice, the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation","volume":"20","author":"Raftai","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-4894(03)00097-3","article-title":"Expression of cysteine proteinases type I & II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis","volume":"103","author":"Rafati","year":"2003","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0014-5793(92)80309-5","article-title":"Imidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microquencing of individual unmodified electroblotted proteins","volume":"296","author":"Oritz","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2005.11.011_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1383-5769(02)00039-9","article-title":"IL-10 leads to a higher parasite persistant mouse model of leishmania major infection","volume":"51","author":"Viana da costa","year":"2002","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2005.11.011_bib19","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying leishmania infantum in tissues of infected mice","author":"Buffet","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2005.11.011_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(05)01282-X","article-title":"Recombinant DNA-derived leishmania proteins: from the laboratory to the field","volume":"5","author":"Kubar","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.011_bib21","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1 and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","article-title":"BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice","volume":"94","author":"Streit","year":"2000","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib23","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Lesihmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib25","first-page":"109","article-title":"Leishmania cysteine proteinases: from gene to subunit vaccine","volume":"4","author":"Rafati","year":"2003","journal-title":"Curr Genome"},{"key":"10.1016\/j.vaccine.2005.11.011_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1369-5274(98)80065-9","article-title":"Role of cysteine proteinases of trypanosomes and Leishmania in host-parasite interaction","volume":"1","author":"Mottram","year":"1998","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1471-4922(03)00038-2","article-title":"Clan CD cysteine proteinases of parasite protozoa","volume":"19","author":"Mottram","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.011_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vetpar.2003.11.013","article-title":"Humoral and cellular immune responses against type I cysteine proteinses of Leishmania infantum are higher in asymptomatic than in symptomatic dogs selected from a naturally infected population","volume":"119","author":"Nakhaee","year":"2004","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.11.011_bib29","first-page":"105","article-title":"T cell response in human leishmaniasis","volume":"65","author":"Babaloo","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2005.11.011_bib30","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon \u03b3","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Nati Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.011_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.011_bib32","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.011_bib33","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.011_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.femsim.2004.05.008","article-title":"Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection","volume":"42","author":"Tewary","year":"2004","journal-title":"FEMS Immunol Med Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:36:16Z","timestamp":1683293776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05011394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X05011394"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}